Original source: https://www.investing.com/news/stock-market-news/fda-reviews-gsks-depemokimab-for-asthma-crswnp-decision-due-dec-16-3901530
FDA reviews GSK’s depemokimab for asthma, CRSwNP; decision due Dec. 16
Tweet on Twitter
Share on Facebook
Google+
Pinterest